Corona Remedies Share Price List At 38% Premium in NSE and BSE Debut

Mumbai, 15 December 2025: Corona Remedies Limited (INE02ZQ01018) made a strong stock market debut on Monday, with its shares listing at a 38% premium or ₹1,470.00, to the issue price of ₹1,062, following the completion of its ₹655.37 crore initial public offering (IPO). The company’s equity shares were listed on both the NSE and BSE, marking its entry into the secondary markets.

Corona Remedies Trades Nearly 34% Above Issue Price on NSE and BSE at Closing

On NSE, as of 15:30 IST the shares closed at ₹1,422.20, down ₹47.80 or 3.25% from the opening price of ₹1,470.00, while remaining up ₹360.20 or 33.92% over the issue price of ₹1,062. The stock recorded a VWAP of ₹1,457.97, with a traded volume of 128.89 lakh shares and a traded value of ₹1,879.17 crore.

The stock saw an intraday high of ₹1,497.80 and a low of ₹1,413.00, reflecting active price movement throughout the session. The company’s total market capitalisation stood at ₹8,698.19 crore. Order book and buy/sell quantity data were not available at the snapshot time.

On BSE, as of 15:30 IST the shares closed at at ₹1,421.00, down ₹31.00 or 2.13% from the previous close of ₹1,062, while remaining up ₹359.00 or 33.80% over the issue price. The stock opened at ₹1,452.00 and recorded an intraday high of ₹1,499.00 and a low of ₹1,412.65, with a VWAP of ₹1,459.38.

Total traded quantity stood at 16.33 lakh shares, with a turnover of ₹238.24 crore. The company’s full market capitalisation was ₹8,690.85 crore, while the free-float market capitalisation was ₹616.61 crore. Market depth data showed active sell-side participation, with 11,029 shares on the buy side and 24,017 shares on the sell side, reflecting robust trading activity. The stock’s 52-week high and low were ₹1,499.00 and ₹1,412.65, respectively, within a 20% price band ranging between ₹1,742.35 and ₹1,161.60.

 Recap and Subscription Status of Corona Remedies IPO

Corona Remedies IPO was a book build issue of ₹655.37 crores. The issue is entirely an offer for sale of 0.62 crore shares of ₹655.37 crore. Corona Remedies IPO bidding started from December 8, 2025, and ended on December10, 2025. The IPO price band was set at ₹1062.00 per share. The lot size for an application was 14, with the minimum amount of investment required by a retail at ₹14,868 (14 shares) (based on upper price).

Corona Remedies IPO was subscribed 144.54 times. The public issue subscribed 30.39 times in the retail category, 293.80 times in QIB (Ex Anchor), and 220.18 times in the NII category.

Corona Remedies has completed its market entry with a premium listing following a ₹655.37 crore offer-for-sale IPO, with shares trading well above the issue price on debut day. Key reference points now remain the listing-day price range, traded volumes, and post-listing disclosures, which together provide a factual baseline for tracking the stock’s transition into regular market trading.

Disclaimer: At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur. 

If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com. 

Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations